News
Tramway Venture Partners
New state Catalyst Fund announces first awards
BY KEVIN ROBINSON-AVILA / JOURNAL STAFF WRITER Many cash-strapped New Mexico startups may soon get a critical boost from a state-backed investment program that’s pumping an initial $4.65 million into three…
$40 Million Investment in New Mexico Startups
Albuquerque, N.M. – Today, Governor Susana Martinez announced $40 million worth of investments in New Mexico startups. A $20 million Catalyst Fund is being launched that will raise a matching $20…
- « Previous
- 1
- 2
- 3
Armonica Technologies
Armonica Announces Appointment of Emily Milsovic as CEO
CARLSBAD, Calif., May 29, 2024 /PRNewswire/ — Armonica, a pioneer in optical epigenetic sequencing has appointed Emily Milsovic as its new chief executive officer (CEO), effective immediately. Ms. Milsovic succeeds…
Armonica Technologies announces Todd Dickinson joins Board of Directors
SAN DIEGO, March 13, 2024 /PRNewswire/ — Armonica Technologies, Inc., a pioneer in sample-prep free direct optical DNA sequencing, today announced the appointment of life science leader Todd Dickinson to the…
Armonica Technologies announces Emily Milsovic joins Board of Directors
SAN DIEGO, Feb. 26, 2024 /PRNewswire/ — Armonica Technologies, Inc., a pioneer in sample-prep free direct optical DNA sequencing, today announced the appointment of biotech veteran Emily Milsovic to the Board…
BennuBio
BennuBio Receives SLAS 2022 Ignite Award
February 27, 2022 BennuBio announced it received the Society for Laboratory Automation and Screening (SLAS) prestigious Ignite award at SLAS’s annual International Conference and Exhibition in Boston, MA on February…
BennuBio Hires Matthew Hess as COO
BennuBio has hired Matthew Hess as Chief Operations Officer. He has over 20 years experience helping start-up companies bring technology to market. With a background in software engineering and experience…
BennuBio moves into larger facility
In response to continuing success of their novel large particle flow cytometer, BennuBio has moved to a larger facility to consolidate engineering, administrative and laboratory in one building. Formerly located…
Circular Genomics
Circular Genomics Announces Launch of MindLight™, the First SSRI Antidepressant Response Test Using Brain-Derived Biomarkers
ALBUQUERQUE, N.M., Sept. 16, 2024 /PRNewswire/ — Circular Genomics, the global leader in circular RNA biomarkers for precision psychiatry and neurology, today announced the launch of MindLight, the first circular…
Circular Genomics Adds Dr. Michael Ackermann, PhD, MBA to its Scientific Advisory Board
ALBUQUERQUE, N.M., March 18, 2024 /PRNewswire/ — Circular Genomics, the global leader in circular RNA biomarkers for precision psychiatry and neurology, today announced the addition of Michael F. Ackermann, PhD,…
Circular Genomics Strengthens Leadership Team with Key Commercial and Research Hires
ALBUQUERQUE, N.M., Feb. 26, 2024 /PRNewswire/ — Circular Genomics, the global leader in advancing circular RNA biomarkers for precision psychiatry and neurology, today announced the appointments of Dave Karlander as…
WaveDyn Vision
Senior Ophthalmology Executive Thomas A. (Tom) Dunlap Joins WaveFront Dynamics Inc. as an Independent Member of the Board of Directors to Support the Company’s Ongoing Commercialization and Broader Strategic Initiatives
ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc. (WDI), a venture backed company and pioneer in wavefront sensing technology for use in measuring and perfecting visual performance, today announced the appointment of Tom…
WaveFront Dynamics Inc. Launches WaveDȳn® Vision Analyzer
ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc., an ophthalmic medical device company, announced today the commercial launch of its dynamic aberrometry measurement system, the WaveDyn Vision Analyzer. The WaveDyn Vision Analyzer (pronounced…
WaveFront Dynamics Inc. Initiates $3mm Series A Round to Fund Continued Development of Dynamic Wavefront Measurement System for Vision Correction
ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc. (WaveDyn™), an early stage ophthalmic medical device company, today announced the first close of a $3 million Series A financing round. The round was led by…
Vitazi.ai
Vitazi.ai Creates a Platform to Deliver Artificial Intelligence to Improve Physician Efficiency and Diagnostics Accuracy
Vitazi.ai is reimagining image-based diagnostics so providers can gain higher quality, real time & trustable health insights. October 8, 2021 Albuquerque, New Mexico — Today Tramway Venture Partners…